Pharmacological rationale for antihypertensive drug choice on COVID‐19–affected patients: ACEI/ARB might not increase their susceptibility

Detalles Bibliográficos
Autores principales: Zhao, Hong‐Jin, Yang, Xiao‐Mei, Wang, Ai‐Hong, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537110/
https://www.ncbi.nlm.nih.gov/pubmed/32942339
http://dx.doi.org/10.1111/jcmm.15850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537110/
https://www.ncbi.nlm.nih.gov/pubmed/32942339
http://dx.doi.org/10.1111/jcmm.15850

Ejemplares similares